| News

BaseLaunch is top European accelerator

21.05.2019

Healthcare Accelerator BaseLaunch, which is operated by the location promotion organization BaselArea.swiss, is among the leading accelerators of its kind in Europe, according to a media report. BaseLaunch is the only Swiss Healthcare Accelerator to feature.

BaseLaunch

“Sifted”, an online magazine supported by the “Financial Times”, has analyzed the leading Healthcare Accelerators in Europe. It aimed to find out which accelerators provide healthcare startups with the best opportunities for development and to find investment.

The list of the best European accelerators that specialize in healthcare is very short, with “Sifted” naming just eleven institutions. BaseLaunch, which is operated by BaselArea.swiss, is the only Swiss institution to feature. According to the article, BaseLaunch is the rarest type of accelerator – it provides investment and support without asking for equity in return. Instead, big industry funding comes from companies like NovartisRocheRoivant SciencesJohnson & JohnsonPfizer and KPMG.

Basel is already world-famous in life sciences, but BaseLaunch is supporting even more startups making exciting developments. It offers them business development and legal services, as well as fully equipped labs. Furthermore, grants are available up to 250,000 Swiss francs per company by the end of the 15-month programme. BaseLaunch looks for companies innovating in the therapeutics space, medtech and diagnostics.

In Germany, the only country in which “Sifted” names several high-ranking healthcare accelerators, there are three institutions listed. Like Switzerland, the other countries featured – Great Britain, Sweden, the Netherlands, Spain, Italy, Denmark and Hungary – have only one accelerator included in the ranking.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

VectivBio secures investments totaling 110 million dollars
Basel Area Business & Innovation, Innovation, Invest

VectivBio secures investments totaling 110 million dollars

The Basel-based biotechnology firm VectivBio has received a capital injection of 110 million US dollars from both new and existing...

Read More
Polyphor receives up to 18 million dollars for development of antibiotics
Basel Area Business & Innovation, Innovation, Invest

Polyphor receives up to 18 million dollars for development of antibiotics

The Allschwil-based company Polyphor has received a second funding award from the global consortium CARB-X to combat antimicrobial resistance. Polyphor...

Read More
What makes Switzerland’s economy resilient in face of COVID pandemic
Basel Area Business & Innovation, Invest

What makes Switzerland’s economy resilient in face of COVID pandemic

The COVID-19 pandemic has hit economies worldwide – and we have not yet overcome it. However, Switzerland is among the...

Read More
DayOne Accelerator applications open
Basel Area Business & Innovation, Innovation

DayOne Accelerator applications open

We are excited to announce the opening of the call for the DayOne Accelerator, now in its 3rd year!

Read More
Matériaux Sabag printing concrete elements
Basel Area Business & Innovation, Innovation, Invest

Matériaux Sabag printing concrete elements

The Jura-based company Matériaux Sabag is now using a 3D printing solution to produce its concrete elements. This approach allows...

Read More
Six companies win the i4Challenge
Basel Area Business & Innovation, Innovation

Six companies win the i4Challenge

The i4Challenge expert jury has selected six winners from 18 finalists. The Industry 4.0 solutions range from 3D printing, IoT,...

Read More
Monte Rosa Therapeutics banks 96 million US dollars
Basel Area Business & Innovation, Innovation, Invest

Monte Rosa Therapeutics banks 96 million US dollars

The Basel-based biotechnology firm Monte Rosa Therapeutics has raised a total of 96 million US dollars after closing a successful...

Read More
Roche launches new coronavirus antibody test
Basel Area Business & Innovation, Innovation, Invest

Roche launches new coronavirus antibody test

Roche is launching on the market a new antibody test to determine coronavirus infections. This should help with the development...

Read More
Investors see great potential in Polyneuron
Basel Area Business & Innovation, Innovation, Invest

Investors see great potential in Polyneuron

The Basel-based company Polyneuron Pharmaceuticals extended its Series A funding round and has now raised a total of 36.5 million...

Read More
Lonza set to manufacture coronavirus drug for Humanigen
Basel Area Business & Innovation, Innovation, Invest

Lonza set to manufacture coronavirus drug for Humanigen

The Basel-based pharmaceutical supplier Lonza is supporting the US firm Humanigen in the development of a potential coronavirus therapeutic. Lonza...

Read More
1 2 3 21

Do you have a question? We'd like to hear from you.